Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Copy number alterations assessed at the single-cell level revealed mono- and polyclonal seeding patterns of distant metastasis in a small-cell lung cancer patient.

Ferronika P, van den Bos H, Taudt A, Spierings DCJ, Saber A, Hiltermann TJN, Kok K, Porubsky D, van der Wekken AJ, Timens W, Foijer F, Colomé-Tatché M, Groen HJM, Lansdorp PM, van den Berg A.

Ann Oncol. 2017 Jul 1;28(7):1668-1670. doi: 10.1093/annonc/mdx182. No abstract available.

PMID:
28419234
2.

Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma.

Zhao N, Wilkerson MD, Shah U, Yin X, Wang A, Hayward MC, Roberts P, Lee CB, Parsons AM, Thorne LB, Haithcock BE, Grilley-Olson JE, Stinchcombe TE, Funkhouser WK, Wong KK, Sharpless NE, Hayes DN.

Lung Cancer. 2014 Nov;86(2):255-61. doi: 10.1016/j.lungcan.2014.08.013. Epub 2014 Aug 30.

3.

Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.

Staaf J, Isaksson S, Karlsson A, Jönsson M, Johansson L, Jönsson P, Botling J, Micke P, Baldetorp B, Planck M.

Int J Cancer. 2013 May 1;132(9):2020-31. doi: 10.1002/ijc.27879. Epub 2012 Oct 20.

4.

Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer.

Sasaki H, Hikosaka Y, Kawano O, Moriyama S, Yano M, Fujii Y.

J Thorac Oncol. 2011 Jan;6(1):15-20. doi: 10.1097/JTO.0b013e31820594f0.

5.

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.

Tran TN, Selinger CI, Kohonen-Corish MR, McCaughan BC, Kennedy CW, O'Toole SA, Cooper WA.

Lung Cancer. 2013 Sep;81(3):462-7. doi: 10.1016/j.lungcan.2013.05.015. Epub 2013 Jun 24.

PMID:
23806793
6.

Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.

Micke P, Edlund K, Holmberg L, Kultima HG, Mansouri L, Ekman S, Bergqvist M, Scheibenflug L, Lamberg K, Myrdal G, Berglund A, Andersson A, Lambe M, Nyberg F, Thomas A, Isaksson A, Botling J.

J Thorac Oncol. 2011 Nov;6(11):1833-40. doi: 10.1097/JTO.0b013e3182295917.

7.

Classification of non-small cell lung cancer based on copy number alterations.

Li BQ, You J, Huang T, Cai YD.

PLoS One. 2014 Feb 5;9(2):e88300. doi: 10.1371/journal.pone.0088300. eCollection 2014.

8.
9.

Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer.

Salido M, Pijuan L, Martínez-Avilés L, Galván AB, Cañadas I, Rovira A, Zanui M, Martínez A, Longarón R, Sole F, Serrano S, Bellosillo B, Wynes MW, Albanell J, Hirsch FR, Arriola E.

J Thorac Oncol. 2011 Jan;6(1):21-7. doi: 10.1097/JTO.0b013e3181fb7cd6.

10.

Thymidylate synthase gene copy number as a predictive marker for response to pemetrexed treatment of lung adenocarcinoma.

Kasai D, Ozasa H, Oguri T, Miyazaki M, Uemura T, Takakuwa O, Kunii E, Ohkubo H, Maeno K, Niimi A.

Anticancer Res. 2013 May;33(5):1935-40.

PMID:
23645741
11.

Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.

Tsao AS, Wei W, Kuhn E, Spencer L, Solis LM, Suraokar M, Lee JJ, Hong WK, Wistuba II.

Clin Lung Cancer. 2011 Nov;12(6):369-74. doi: 10.1016/j.cllc.2011.02.002. Epub 2011 May 17.

12.

Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.

He YY, Zhang XC, Yang JJ, Niu FY, Zeng Z, Yan HH, Xu CR, Guan JL, Zhong WZ, Yang LL, Guo LH, Wu YL.

Clin Lung Cancer. 2014 Nov;15(6):441-7. doi: 10.1016/j.cllc.2014.06.006. Epub 2014 Jun 23.

PMID:
25044104
13.

Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.

Lee HW, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, Lee JI, Nam DH.

Int J Oncol. 2012 Dec;41(6):2013-20. doi: 10.3892/ijo.2012.1663. Epub 2012 Oct 15.

PMID:
23076643
14.

[Association of molecular biology of lung cancers and their metastasis and prognosis].

Mao YS, Gao YN, He J.

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):632-4. Review. Chinese. No abstract available.

PMID:
17236563
15.

Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas.

Tsuta K, Mimae T, Nitta H, Yoshida A, Maeshima AM, Asamura H, Grogan TM, Furuta K, Tsuda H.

Hum Pathol. 2013 Jun;44(6):975-82. doi: 10.1016/j.humpath.2012.09.002. Epub 2012 Dec 23.

PMID:
23266446
16.

MicroRNAs in non-small cell lung cancer invasion and metastasis: from the perspective of the radiation oncologist.

Verma V, Lautenschlaeger T.

Expert Rev Anticancer Ther. 2016 Jul;16(7):767-74. doi: 10.1080/14737140.2016.1191950. Epub 2016 Jun 1. Review.

PMID:
27215143
17.

Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors.

Italiano A, Vandenbos FB, Otto J, Mouroux J, Fontaine D, Marcy PY, Cardot N, Thyss A, Pedeutour F.

Ann Oncol. 2006 Jun;17(6):981-5. Epub 2006 Mar 8.

PMID:
16524970
18.

[Clinical significance of cytokeratin 19 mRNA expression in peripheral leucocytes in patients with non-small cell lung cancer].

Wang ZH, Kong L, Liu J.

Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):53. Chinese. No abstract available.

PMID:
17575695
19.

Differences of gene expression in non-small cell lung cancer: are histology, tumor site, and methodology relevant?

Toffalorio F, De Pas T, Giovannetti E.

J Thorac Oncol. 2010 Aug;5(8):1310-1; author reply 1311. doi: 10.1097/JTO.0b013e3181e7c165. No abstract available.

20.

c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.

Tsuta K, Kozu Y, Mimae T, Yoshida A, Kohno T, Sekine I, Tamura T, Asamura H, Furuta K, Tsuda H.

J Thorac Oncol. 2012 Feb;7(2):331-9. doi: 10.1097/JTO.0b013e318241655f.

Supplemental Content

Support Center